Arrhythmia Research (HRT) Q1 Profit Slips Amid Stronger Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
ATRA, GECC, BTU, More
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
ATRA, GECC, BTU, More
Join SI Premium – FREE
Arrhythmia Research Technology, Inc. (NYSE: HRT) reported Q1 EPS of $0.01, versus $0.04 reported last year. Revenue for the quarter came in at $6.18 million, versus $5.59 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Forum Energy Technologies (FET) Tops Q3 EPS by 29c ; Offers Guidance
- TFS Financial (TFSL) Reports In-Line Q4 EPS
- American Savings Bank, National Association (ASBH) Tops Q3 EPS by 46c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
